Axsome Therapeutics, Inc. (AXSM)
177.27
+3.13
(+1.80%)
USD |
NASDAQ |
Jan 16, 16:00
177.25
-0.02
(-0.01%)
After-Hours: 20:00
Axsome Therapeutics Market Cap: 8.937B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.653B |
| Gilead Sciences, Inc. | 154.97B |
| Vanda Pharmaceuticals, Inc. | 441.45M |
| Amicus Therapeutics, Inc. | 4.421B |
| MannKind Corp. | 1.600B |
Market Cap Related Metrics
| PS Ratio | 15.55 |
| Price to Book Value | 121.21 |
| Price | 177.27 |
| Earnings Yield | -2.64% |